S

START Center for Cancer Research

Phase 1 cancer trials with genomic profiling

Interventional Radiologist

Physicians & SurgeonsConfirmed live in the last 24 hours
Full-timeLogroño, La Rioja, SpainNo salary listedIn-person

About the Job

Requirements

  • Specialty training via MIR in Radiodiagnosis or an equivalent qualification recognized in Spain.
  • Training and experience in Interventional Radiology.
  • Ability to work in a team and a patient-centered approach.
  • Commitment to quality of care and continuous improvement.

Responsibilities

  • Provide care involving arterial, venous, portal, and hepatic vascular pathology and therapeutic embolization.
  • Perform interventional oncology procedures, including chemoembolization (TACE) and radioembolization (TARE, Y-90).
  • Perform percutaneous tumor ablation using radiofrequency, microwave, cryoablation, and irreversible electroporation in the liver, kidney, lung, bone, and other sites.
  • Perform image-guided biopsies, including percutaneous biopsies guided by ultrasound, computed tomography, or fluoroscopy.
  • Perform percutaneous drainage of abscesses and collections in the abdomen, pelvis, and thorax, as well as pleural and thoracic collection drainage.
  • Perform biliary procedures, including percutaneous biliary drainage, biliary stent placement, cholecystostomy, and treatment of stones or stenoses.
  • Perform urinary tract procedures, including percutaneous nephrostomy, antegrade ureteral stent placement, and management of stenoses.
  • Perform digestive tract procedures, including percutaneous gastrostomy and gastrojejunostomy, and esophageal, duodenal, and colonic stent placement.

About the Company

START Center for Cancer Research

Phase 1 cancer trials with genomic profiling

START Center for Cancer Research runs Phase 1 clinical trials for novel anti-cancer therapies through a network of research sites in the United States, Spain, Portugal, and Ireland. It connects patients with early-stage trials, supported by genetic tumor profiling, multi-disciplinary care, and state-of-the-art treatment technology, to test new drugs before they reach broader use. The center distinguishes itself by its large, community-based trial network with 40+ principal investigators and a track record of conducting over 1,500 early-phase trials, including 50 therapies that later gained FDA/EMA approval. Its goal is to speed the translation of clinical research into available treatments and to expand access to innovative options for patients and physicians worldwide.

Company size
11-50
Company stage
Not listed
Total funding
Not listed
Headquarters
San Antonio, TX
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at START Center for Cancer Research

See more jobs